Yes, I do. Most or nearly all of the institutions are friends of Marty. They have a longer horizon than WSt.
If he succeeds, this could be the Google of Health, and with an increase in price accordingly.
Tracey, there are still more than 6million shares short, and no volume in the stock. Once this thing goes up, it might go through the roof.
Steve, I've said it before: I don't think Marty is ever going to sell this company!
He is turning it into a one stop shop for all Health Issues.
Walgreens for prescriptions
The next thing might be insurance
and so on, and so on.
But always with partnerships, and he keeps the company and slowly turns it into a something where employees have the say.
I don’t think this stock will ever see 30 again. The reasons:
Volume has dried up even with the market going down.
Shorts, who always know something, have bought back 1million shares.
On October 1st, only just two weeks ago, the CEO stated the company is back to being a growth company. He can’t do that if he knows something that would contradict this. For once the SEC would be after him.
And why haven’t we got a date concerning the 3rd quarter earnings? Are they waiting for the dust to settle?
The current rules leave the door wide open for all sorts of stock manipulation.
BTW, I’m perhaps a bit naïve, but if the SEC does not object to Marty’s fiddling, can somebody please explain to me at what kind of manipulation they frown upon?
Thanks, I do understand the procedure.
However, I do think it would me more just if the price were fixed at the moment the options were authorized by the shareholders.
After all, without that, the shareholders really have no idea what they authorize!
They might as well leave the decision about the whole circus to management!
Having thought about these options I would like to ask a more fundamental question :
It is really the shareholders who grant these options, not the management.
So wouldn’t it be more reasonable to have the price fixed at the time of the granting by the shareholders?
Well given last year’s action and the fact we are already down about 24% I would think and hope this is going to turn around this coming week. After all, Marty wouldn’t want a SEC investigation.
Behaviour of WBMD around the tender of 2013
07.08.2013 $33.70 announcement of tender at $34.00
10.09.2013 $33.46 end of tender
25.09.2013 $28.33 low price at less 16%
29.10.2013 $36.84 plus 08.35% above tender
14.11.2013 $40.32 plus 11.75% above tender
17.01.2014 $49.56 plus 45.76% above tender
Of course, this time around it’s a bit different, if only because of the change in the number of outstanding shares.
At what time is the price per share of the granted options fixed?
Is it at the time they were approved by the shareholders?
Just to know whether there is any incentive for Marty to get an even lower price…
Well, at this moment it certainly doesn’t look like it.
If there were any honour amongst WBMD’s management, they would be buying now to show the world that Stifel Nicolaus are wrong and they themselves didn’t know in advance about this downgrade.
But then we all know there is no honour amongst thieves.
According to the Henry J. Kaiser Family Foundation, total sales of prescription drugs in the US in 2013 were more than $ 235billion.
The Walgreen Company (Walgreens) is the largest drug retailing chain in the United States. As of May 31, 2014, the company operated 8,217 stores in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. It was founded in Chicago, Illinois, in 1901. The Walgreens headquarters office is in the Chicago suburb of Deerfield, Illinois.
August 6, 2014: Walgreens exercised its option to purchase the remaining 55% of Alliance Boots. The combined company is to be known as Walgreens Boots Alliance with headquarters in Chicago.
Alliance Boots employs over 108,000 staff and operates more than 3,150 retail stores, of which just over 3,050 have pharmacies. Alliance Boots pharmaceutical wholesale division serves over 180,000 pharmacies, doctors, hospitals and health centers from over 370 distribution centers in 20 countries.
“WebMD will make Walgreens' online prescription refill and transfer services and Healthcare Clinic appointment scheduling available across WebMD's desktop and mobile offerings.”
Is Marty back in the drug business? A new source of income?
Well, the creator of Medco should know how to make money out of that business!
This new partnership with Walgreens is the result of WebMD’s collaboration with Boots in Britain. Alex Gourlay, with whom they are going to work, is the former Managing Director of Boots UK and the co-chairman of a Forum that advises the UK Government.
They confirmed their guidance of about six weeks ago; they didn’t announce they would boost the stock, as some well-known bad mouth wants us to believe.
But as they confirmed their guidance, and business is excellent, and $48.50 was a good price to buy back 2million shares, I would think they should jump on this opportunity when they could buy back shares at the current low prices.